½ÃÀ庸°í¼­
»óǰÄÚµå
1609000

¼¼°èÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå : À¯Çü, ±â¼ú, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Medical Elastomers Market by Type (Thermoplastic Elastomers, Thermoset Elastomers), Technology (Compression Molding, Extrusion Tubing, Injection Molding), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀº 2023³â¿¡ 34¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 37¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.26%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 68¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó´Â À¯¿¬¼º, »ýüÀûÇÕ¼º, ³»¾àǰ¼ºÀÌ ³ô°Ô Æò°¡µÇ°í ÀÖ´Â Æú¸®¸ÓÀÇ ÀÏÁ¾À¸·Î, ÀÇ·á ¿ëµµ¿¡ À־ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Ä«Å×ÅÍ, ÀÓÇöõÆ® µîÀÇ ÀÇ·á Á¦Ç°¿¡ Æø³Ð°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °ßÀÎ ¶ÇÇÑ COVID-19ÀÇ ´ëÀ¯ÇàÀº ź·ÂÀÖ´Â ÀÇ·á ¿ëǰÀÇ Á߿伺À» °­Á¶ÇÏ°í °í¼º´É ¿¤¶ó½ºÅä¸Ó¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æ µî °úÁ¦¿¡ Á÷¸éÇϰí ÀÖÀ¸¸ç, À̰ÍÀÌ ±â¼ú Çõ½Å°ú ½ÃÀå ÅõÀÔ±îÁöÀÇ ½Ã°£À» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ±âȸ´Â ȯ°æ ģȭÀû ÀÎ ÀÇ·á Á¦Ç°À» ¿ä±¸ÇÕ´Ï´Ù. ¹ÙÀÌ¿ÀÀ¸·Î Áö¼Ó °¡´ÉÇÑ ¿¤¶ó½ºÅä¸Ó¸¦ °³¹ßÇÏ´Â °Íµµ ÀÖ½À´Ï´Ù. ´Ù¸¥ ±â´É¼º °áÇÕµÈ ÇÏÀ̺긮µå Àç·áÀÇ Çõ½ÅÀº ¶ÇÇÑ ÀÇ·á ¿ëµµÀÇ È¹±âÀûÀÎ Áøº¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ÅõÀÚ´Â ±â¾÷¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ ±â¾÷Àº ¿¬±¸ ±â°ü°ú Çù·Â °ü°è¸¦ ±¸ÃàÇÏ°í »ýü ÀûÇÕ¼ºÀÇ ±âÁذú ±â¼úÀÇ Áøº¸¸¦ Ç×»ó ÆÄ¾ÇÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. M&A¿¡ ÀÇÇØ Á¦Ç° Æ÷Æ®ÇÁ Àü ¼¼°èÀûÀ¸·Î ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀº Áö¼Ó°¡´ÉÇÑ Çõ½Å°ú ÇコÄÉ¾î ±âÁØ¿¡ ºÎÇÕÇÏ´Â °ÍÀ» ¿ì¼±½ÃÇϰí ÁÖ¿ä ÇѰ踦 ´Ù·ç¸é ¼ºÀåÇϴ ż¼°¡ Áõ°¡ÇÕ´Ï´Ù. °®Ãß¾îÁ® ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 34¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 37¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 68¾ï 5,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 10.26%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀÏȸ¿ë ÀÇ·á±â±âÀÇ Á¦Á¶¿¡ À־ÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸ÓÀÇ »ç¿ë È®´ë
    • Áß¿äÇÑ ÀÓÇöõÆ®ÀÇ Á¦Á¶ ¼ö¿ä
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç° °³¹ß¿¡ ÇÊ¿äÇÑ °í¾×ÀÇ ÅõÀÚ¿Í ½Ã°£
  • ½ÃÀå ±âȸ
    • ¿­°¡¼Ò¼º ¿¤¶ó½ºÅä¸Ó °¡°ø »ê¾÷ÀÇ Áøº¸
    • ±Ý¼Ó¿¡¼­ ÀÇ·á¿ë ÇÃ¶ó½ºÆ½À¸·Î ´ëü
  • ½ÃÀåÀÇ °úÁ¦
    • ¹° ¿¤¶ó½ºÅä¸ÓÀÇ È¯°æ¿¡ ´ëÇÑ ¿µÇâ

Porter's Five Forces : ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀÏȸ¿ë ÀÇ·á±â±âÀÇ Á¦Á¶¿¡ À־ÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸ÓÀÇ »ç¿ë Áõ°¡
      • Áß¿äÇÑ ÀÓÇöõÆ® »ý»ê¿¡ ´ëÇÑ ¼ö¿ä
    • ¾ïÁ¦¿äÀÎ
      • Á¦Ç° °³¹ß¿¡´Â ´Ù¾×ÀÇ ÅõÀÚ¿Í ½Ã°£ÀÌ ÇÊ¿ä
    • ±âȸ
      • ¿­°¡¼Ò¼º ¿¤¶ó½ºÅä¸Ó °¡°ø »ê¾÷ÀÇ ¹ßÀü
      • ÀÇ·á¿ë ÇÃ¶ó½ºÆ½¿¡ ÀÇÇÑ ±Ý¼ÓÀÇ ´ëü
    • °úÁ¦
      • ¹° ¿¤¶ó½ºÅä¸ÓÀÇ È¯°æ ¿µÇâ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå : À¯Çüº°

  • ¿­°¡¼Ò¼º ¿¤¶ó½ºÅä¸Ó
  • ¿­°æÈ­¼º ¿¤¶ó½ºÅä¸Ó

Á¦7Àå ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå : ±â¼úº°

  • ¾ÐÃà ¼ºÇü
  • ¾ÐÃâ Æ©ºê
  • »çÃâ ¼ºÇü

Á¦8Àå ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå : ¿ëµµº°

  • Ä«Å×ÅÍ
  • Àå°©
  • ÀÓÇöõÆ®
  • ÀÇ·á¿ë °¡¹æ
  • ÀÇ·á¿ë Æ©ºê
  • ÁÖ»ç±â

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Apar Industries Ltd
  • Asahi Kasei Corporation
  • BASF SE
  • Biomerics, LLC
  • Celanese Corporation
  • DuPont de Nemours, Inc.
  • Foster Corporation
  • Hexpol AB
  • Koninklijke DSM NV,
  • Kraton Corporation
  • Kuraray Co. Ltd.
  • Momentive Performance Materials Inc.
  • Polyone Corporation
  • Raumedic AG
  • RTP Company, Inc.
BJH 24.12.19

The Medical Elastomers Market was valued at USD 3.45 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 10.26%, to USD 6.85 billion by 2030.

Medical elastomers are a class of polymers highly valued for their flexibility, biocompatibility, and chemical resistance, making them crucial in medical applications. They find extensive use in creating medical products like tubes, stoppers, medical bags, catheters, and implants due to their excellent durability and adaptability. The demand for medical elastomers is driven by advancements in healthcare infrastructure, an increase in the aging population, and a rising preference for minimally invasive surgical procedures that require sophisticated medical devices. Moreover, the COVID-19 pandemic has underscored the importance of resilient medical supplies, amplifying the need for high-performance elastomers. However, market growth faces challenges such as stringent regulatory environments governing medical material approvals, which can stifle innovation and time-to-market. Also, the high cost of raw materials and the technology-intensive nature of production processes pose significant entry barriers. Key growth opportunities lie in the development of bio-based and sustainable elastomers, aligning with global trends toward eco-friendly medical products. There is also a potential for expansion in emerging markets where healthcare systems are rapidly evolving. Innovations in hybrid materials combining elastomeric properties with other functionalities can also lead to breakthroughs in medical applications. It's crucial for businesses to invest in R&D for developing cost-effective and regulatory-compliant elastomers that address specific medical needs. Companies should also establish collaborations with research institutions to keep abreast of biocompatibility standards and technological advancements. While the market is currently fragmented with high competition, strategic mergers and acquisitions can provide an expanded product portfolio and improved market access. Overall, the medical elastomers market is poised for growth if key limitations are addressed, with priority given to sustainable innovation and compliance with healthcare standards.

KEY MARKET STATISTICS
Base Year [2023] USD 3.45 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 6.85 billion
CAGR (%) 10.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Elastomers Market

The Medical Elastomers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing use of medical elastomers in the production of disposable medical equipment
    • Demand for the production of critical implants
  • Market Restraints
    • High investment and time required for products development
  • Market Opportunities
    • Advancement in thermoplastics elastomer processing industry
    • Replacement of metal with the medical plastics
  • Market Challenges
    • Environment effect of wate elastomers

Porter's Five Forces: A Strategic Tool for Navigating the Medical Elastomers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Elastomers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Elastomers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Elastomers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Elastomers Market

A detailed market share analysis in the Medical Elastomers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Elastomers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Elastomers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Elastomers Market

A strategic analysis of the Medical Elastomers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Elastomers Market, highlighting leading vendors and their innovative profiles. These include Apar Industries Ltd, Asahi Kasei Corporation, BASF SE, Biomerics, LLC, Celanese Corporation, DuPont de Nemours, Inc., Foster Corporation, Hexpol AB, Koninklijke DSM N.V.,, Kraton Corporation, Kuraray Co., Ltd., Momentive Performance Materials Inc., Polyone Corporation, Raumedic AG, and RTP Company, Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Elastomers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Thermoplastic Elastomers and Thermoset Elastomers.
  • Based on Technology, market is studied across Compression Molding, Extrusion Tubing, and Injection Molding.
  • Based on Application, market is studied across Catheters, Gloves, Implants, Medical Bags, Medical Tubes, and Syringes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of medical elastomers in the production of disposable medical equipment
      • 5.1.1.2. Demand for the production of critical implants
    • 5.1.2. Restraints
      • 5.1.2.1. High investment and time required for products development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in thermoplastics elastomer processing industry
      • 5.1.3.2. Replacement of metal with the medical plastics
    • 5.1.4. Challenges
      • 5.1.4.1. Environment effect of wate elastomers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Elastomers Market, by Type

  • 6.1. Introduction
  • 6.2. Thermoplastic Elastomers
  • 6.3. Thermoset Elastomers

7. Medical Elastomers Market, by Technology

  • 7.1. Introduction
  • 7.2. Compression Molding
  • 7.3. Extrusion Tubing
  • 7.4. Injection Molding

8. Medical Elastomers Market, by Application

  • 8.1. Introduction
  • 8.2. Catheters
  • 8.3. Gloves
  • 8.4. Implants
  • 8.5. Medical Bags
  • 8.6. Medical Tubes
  • 8.7. Syringes

9. Americas Medical Elastomers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Elastomers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Elastomers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apar Industries Ltd
  • 2. Asahi Kasei Corporation
  • 3. BASF SE
  • 4. Biomerics, LLC
  • 5. Celanese Corporation
  • 6. DuPont de Nemours, Inc.
  • 7. Foster Corporation
  • 8. Hexpol AB
  • 9. Koninklijke DSM N.V.,
  • 10. Kraton Corporation
  • 11. Kuraray Co., Ltd.
  • 12. Momentive Performance Materials Inc.
  • 13. Polyone Corporation
  • 14. Raumedic AG
  • 15. RTP Company, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦